Cancer systems biology in the genome sequencing era: Part 2, evolutionary dynamics of tumor clonal networks and drug resistance

Abstract

A tumor often consists of multiple cell subpopulations (clones). Current chemo-treatments often target one clone of a tumor. Although the drug kills that clone, other clones overtake it and the tumor reoccurs. Genome sequencing and computational analysis allows to computational dissection of clones from tumors, while singe-cell genome sequencing including RNA-Seq allows to profiling of these clones. This opens a new window for treating a tumor as a system in which clones are evolving. Future cancer systems biology studies should consider a tumor as an evolving system with multiple clones. Therefore, topics discussed in Part 2 of this review include evolutionary dynamics of clonal networks, early-warning signals for formation of fast-growing clones, dissecting tumor heterogeneity, and modeling of clone-clone-stroma interactions for drug resistance. The ultimate goal of the future systems biology analysis is to obtain a whole-system understanding of a tumor and therefore provides a more efficient and personalized management strategies for cancer patients.

2 figs. Related papers can be found at http://www.cancer-systemsbiology.org, Seminar in Cancer Biology, 2013

References in corpus (6)

• ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context
• Principles of microRNA regulation of a human cellular signaling network
• Understanding genomic alterations in cancer genomes using an integrative network approach
• Cancer systems biology in the genome sequencing era: Part 1, dissecting and modeling of tumor clones and their networks
• Self-organization of gene regulatory network motifs enriched with short transcript's half-life transcription factors
• Cancer systems biology: exploring cancer-associated genes on cellular networks

Cited by in corpus (3)

• Predictive genomics: A cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data
• Signaling Network Assessment of Mutations and Copy Number Variations Predicts Breast Cancer Subtype-specific Drug Targets
• Cancer systems biology in the genome sequencing era: Part 1, dissecting and modeling of tumor clones and their networks